489 related articles for article (PubMed ID: 15130417)
21. No evidence for oxidative stress as a mechanism of action of hyperhomocysteinemia in humans.
Huerta JM; González S; Fernández S; Patterson AM; Lasheras C
Free Radic Res; 2004 Nov; 38(11):1215-21. PubMed ID: 15621699
[TBL] [Abstract][Full Text] [Related]
22. The progress of inflammation and oxidative stress in patients with chronic kidney disease.
Xu G; Luo K; Liu H; Huang T; Fang X; Tu W
Ren Fail; 2015 Feb; 37(1):45-9. PubMed ID: 25375354
[TBL] [Abstract][Full Text] [Related]
23. Hyperhomocysteinemia in relation to plasma free amino acids, biomarkers of inflammation and mortality in patients with chronic kidney disease starting dialysis therapy.
Suliman ME; Stenvinkel P; Qureshi AR; Bárány P; Heimburger O; Anderstam B; Alvestrand A; Lindholm B
Am J Kidney Dis; 2004 Sep; 44(3):455-65. PubMed ID: 15332218
[TBL] [Abstract][Full Text] [Related]
24. Circulating levels of adhesion molecules in chronic kidney disease correlate with the stage of renal disease and with C-reactive protein.
Vaccaro F; Mulè G; Cottone S; Soresi M; Giannitrapani L; Vadalà A; Sparacino V; Calabrese S; Picone FP; Montalto G; Cerasola G
Arch Med Res; 2007 Jul; 38(5):534-8. PubMed ID: 17560459
[TBL] [Abstract][Full Text] [Related]
25. Tumour necrosis factor alpha, lipid peroxidation and NO* are increased and associated with decreased free-radical scavenging enzymes in patients with Weill-Marchesani syndrome.
Evereklioglu C; Turkoz Y; Calis M; Duygulu F; Karabulut AB
Mediators Inflamm; 2004 Jun; 13(3):165-70. PubMed ID: 15223607
[TBL] [Abstract][Full Text] [Related]
26. Plasma pentosidine and total homocysteine levels in relation to change in common carotid intima-media area in the first year of dialysis therapy.
Suliman ME; Stenvinkel P; Jogestrand T; Maruyama Y; Qureshi AR; Bárány P; Heimbürger O; Lindholm B
Clin Nephrol; 2006 Dec; 66(6):418-25. PubMed ID: 17176913
[TBL] [Abstract][Full Text] [Related]
27. Association between elevated visfatin and carotid atherosclerosis in patients with chronic kidney disease.
Tang X; Chen M; Zhang W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Jun; 38(6):553-9. PubMed ID: 23828708
[TBL] [Abstract][Full Text] [Related]
28. Oxidative DNA damage correlates with carotid artery atherosclerosis in hemodialysis patients.
Ari E; Kaya Y; Demir H; Cebi A; Alp HH; Bakan E; Odabasi D; Keskin S
Hemodial Int; 2011 Oct; 15(4):453-9. PubMed ID: 22111813
[TBL] [Abstract][Full Text] [Related]
29. [Effects of Salvia miltiorrhiza on oxidative stress and microinflammatory state in patients undergoing continuous hemodialysis].
Pu C; Yang YB; Sun QL
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Sep; 26(9):791-4. PubMed ID: 17058827
[TBL] [Abstract][Full Text] [Related]
30. [Effect of folic acid supplementation on total homocysteine levels in hemodialysis patients].
Armada E; Pérez Melón C; Otero A; Gayoso P; Rodríguez M; Esteban Morcillo J
Nefrologia; 2001; 21(2):167-73. PubMed ID: 11464650
[TBL] [Abstract][Full Text] [Related]
31. Oxidative stress in haemodialysis.
Loughrey CM; Young IS; Lightbody JH; McMaster D; McNamee PT; Trimble ER
QJM; 1994 Nov; 87(11):679-83. PubMed ID: 7820542
[TBL] [Abstract][Full Text] [Related]
32. Potential cardiovascular risk factors in chronic kidney disease: AGEs, total homocysteine and metabolites, and the C-reactive protein.
Busch M; Franke S; Müller A; Wolf M; Gerth J; Ott U; Niwa T; Stein G
Kidney Int; 2004 Jul; 66(1):338-47. PubMed ID: 15200442
[TBL] [Abstract][Full Text] [Related]
33. Oxidative stress markers and C-reactive protein in pediatric patients on hemodialysis.
Elshamaa MF; Sabry S; Nabih M; Elghoroury EA; El-Saaid GS; Ismail AA
Ann Nutr Metab; 2009; 55(4):309-16. PubMed ID: 19828941
[TBL] [Abstract][Full Text] [Related]
34. [Inflammatory status in patients with end-stage renal disease: role of monocyte activation].
Liang M; Wang L; Hou FF; Liu J; Liu ZQ; Tian JW
Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug; 23(8):781-4. PubMed ID: 12919896
[TBL] [Abstract][Full Text] [Related]
35. Relationship of pregnancy-associated plasma protein-a to renal function and dialysis modalities.
Fialová L; Kalousová M; Soukupová J; Sulková S; Merta M; Jelínková E; Horejsí M; Srámek P; Malbohan I; Mikulíková L; Tesar V; Zima T
Kidney Blood Press Res; 2004; 27(2):88-95. PubMed ID: 14739577
[TBL] [Abstract][Full Text] [Related]
36. Plasma homocysteine is a determinant of tissue necrosis factor-alpha in hypertensive patients.
Bogdanski P; Pupek-Musialik D; Dytfeld J; Lacinski M; Jablecka A; Jakubowski H
Biomed Pharmacother; 2008; 62(6):360-5. PubMed ID: 18093792
[TBL] [Abstract][Full Text] [Related]
37. Inflammatory cytokines and malnutrition as related to risk for cardiovascular disease in hemodialysis patients.
Perunicic-Pekovic G; Pljesa S; Rasic-Milutinovic Z; Stankovic S; Ilic M; Maletic R
Can J Physiol Pharmacol; 2008 Apr; 86(4):205-9. PubMed ID: 18418430
[TBL] [Abstract][Full Text] [Related]
38. Plasma homocysteine and markers for oxidative stress and inflammation in patients with coronary artery disease--a prospective randomized study of vitamin supplementation.
Jonasson T; Ohlin AK; Gottsäter A; Hultberg B; Ohlin H
Clin Chem Lab Med; 2005; 43(6):628-34. PubMed ID: 16006259
[TBL] [Abstract][Full Text] [Related]
39. C-reactive protein, lipoprotein(a), homocysteine, and male sex contribute to carotid atherosclerosis in peritoneal dialysis patients.
Ohkuma T; Minagawa T; Takada N; Ohno M; Oda H; Ohashi H
Am J Kidney Dis; 2003 Aug; 42(2):355-61. PubMed ID: 12900819
[TBL] [Abstract][Full Text] [Related]
40. What is the meaning of homocysteine in patients on dialysis?
Silva de Almeida CC; Guerra DC; Vannucchi MT; Geleilete TJ; Vannucchi H; Chiarello PG
J Ren Nutr; 2011 Sep; 21(5):394-400. PubMed ID: 21439851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
